Requip 5mg
Available Dosages
| SKU | 893 |
|---|---|
| Generic For | Requip |
| Strength | 5 mg |
| Manufacturer | GSK, England |
| Active Ingredient | Ropinirole |
Out Of Stock
Requip 5mg (Ropinirole)
Requip 5MG (Ropinirole)
Requip 5mg contains the active ingredient Ropinirole, which is included among the class of dopamine agonists. This medicine is widely used to treat Parkinson's disease and restless legs syndrome (RLS). It can replace dopamine, a natural substance in the brain that helps you control nerve to control body movement
What is Requip 5mg used for?
Requip 5mg is prescribed to treat Parkinson’s disease. This drug should be taken under prescription, and it may harm you if you have no signs of illness. It’s easy to switch patients from Ropinirole immediate release tablets to ropinirole prolonged-release tablets.
How does Requip 5mg work?
The active ingredient of Requip 5mg, Ropinirole belongs to a group of medicines called dopamine agonists that can affect the brain’s natural substance called dopamine. Low level of dopamine raises the risks of Parkinson’s disease, and Ropinirole has similar effects like dopamine. Requip 5mg should be taken under a physician’s prescription and its progress should be monitored regularly.
What does Requip 5mg contain?
Requip 5mg tablet contains 5mg of the active component Ropinirole.
What are the side effects of Requip 5mg?
There are some common side effects of Requip 5mg, such as:
- Inability to control your impulse, drive or temptation to perform an action
- Strong impulse
- Short temper and eagerness to gamble excessively
- Decreased sensitivity to touch
- Frequent or urgent need to urinate
- Altered or increased sexual interest and behavior of significant concern to you or to others
- Fever, stiff muscles, confusion, sweating, fast or uneven heartbeats
- Uncontrollable excessive shopping or spending
- Eating disorder or taking large amounts of food in a short time period
- Swelling in your hands, arms, feet, ankles, or lower legs
- Disturbance in appetite
Some rare side effects of Requip 5mg include:
- Feeling dizzy or faint, especially when you stand up suddenly (this is caused by a drop in blood pressure)
- Drowsiness or falling asleep very suddenly without feeling sleepy first (sudden sleep onset episodes)
- Mental or psychological problems such as delirium (severe confusion), delusions (unreasonable ideas) or paranoia (unreasonable suspicions).
What medications interact with Requip 5mg?
There are some drugs or medicinal elements that may interact with Requip 5mg. These medications include:
- Kava
- Antipsychotic medications like chlorpromazine, haloperidol, thiothixene
- Any antidepressants
- Warfarin (Coumadin)
- Metoclopramide
- Ciprofloxacin (Cipro)
Tell your doctor about all prescription, non-prescription, illegal, recreational, herbal, nutritional, or dietary drugs that you are taking along with Requip 5mg.
Some other medications are also there that can influence the effectiveness. These medications are , omeprazole, rifampin, cimetidine, fluvoxamine, mexiletine, drugs to treat seizures (such as carbamazepine, phenobarbital), etc.
When should Requip 5mg not be used?
These you already have some conditions, then talk to your doctor before taking Requip 5mg. These conditions are:
- If you are breastfeeding
- If you have an intolerance to some sugars (such as lactose)
- If you are under 18 years old
- If you are pregnant or think you may be pregnant
- If you have a history of or have experienced any unusual urges and/or behaviors (such as excessive gambling or excessive sexual behavior
- If you have a serious heart complaint
- If you have a history of or currently have a serious mental health problem
How should Requip 5mg be used?
The accurate dose of Requip 5mg tablets is based on the total daily dose of immediate-release formulation that the patient was receiving. The recommended dose for switching from Ropinirole immediate release tablets to Ropinirole prolonged-release tablets are provided by your doctor.
Missed dose of Requip 5mg
Do not take a double dose to make up for a missed dose. If you have forgotten to take Requip 5mg for one day or more, ask your doctor or nurse for advice on how to start taking it again.
How should Requip 5mg be stored?
Do not store this drug at above 25°C. Keep Requip 5mg out of reach of children as well as moisture and direct heat.
What is Requip 5mg used for?
Requip 5mg contains ropinirole 5mg in an immediate-release (IR) tablet, used for Parkinson's disease management and restless legs syndrome (RLS). The 5mg IR dose is a higher maintenance dose used in patients who have been titrated upward from lower doses. For Parkinson's disease, immediate-release ropinirole is taken three times daily to maintain dopaminergic stimulation throughout the day. It is also used in RLS, where ropinirole significantly reduces the urge-to-move and sensory discomfort in legs, particularly at night.
How does immediate-release ropinirole 5mg differ from ropinirole XL?
Ropinirole IR (immediate-release) 5mg reaches peak plasma levels within 1–2 hours and requires three-times-daily dosing to maintain consistent dopaminergic effect throughout the day. Ropinirole XL provides sustained plasma levels over 24 hours with once-daily dosing. For Parkinson's disease, XL is preferred for simplicity and smoother motor control. IR is used when more precise dose control is needed, when transitioning between doses, or in patients who prefer or require the IR formulation. For RLS, IR provides targeted evening dosing.
How should Requip 5mg IR be taken for Parkinson's disease?
Requip 5mg IR is taken three times daily — typically with meals to reduce nausea. The total daily dose of 15mg (three 5mg tablets) represents a moderate-to-high ropinirole dose for established Parkinson's disease. Start at 0.25mg three times daily and increase by 0.25mg TID per week to reach the effective dose. Take at consistent times. If nausea is problematic, domperidone (where available) can be taken 20 minutes before each ropinirole dose during titration. Never abruptly stop — taper over at least 1 week.
How is Requip 5mg used for restless legs syndrome?
For RLS, ropinirole is taken as a single daily dose 1–3 hours before bedtime, rather than multiple times daily. The dose is titrated from 0.25mg nightly, increasing weekly to the effective dose (typically 0.5–4mg nightly — a much lower total dose than for Parkinson's). The 5mg dose would be unusually high for RLS and suggests advanced RLS or augmentation (worsening of RLS symptoms from long-term dopaminergic therapy). Augmentation requires specialist reassessment and possible dose reduction or alternative therapy.
Are there risks of augmentation with ropinirole 5mg for RLS?
Augmentation — the paradoxical worsening of RLS symptoms with long-term dopamine agonist therapy — is a clinically important concern. It manifests as symptoms appearing earlier in the day, spreading to new body areas, or becoming more intense despite increasing the dose. Risk increases with higher doses and longer treatment duration. A dose of 5mg IR for RLS may indicate augmentation or inadequate initial dose selection. Treatment of augmentation includes dose reduction, switching to non-dopaminergic RLS treatments (gabapentin, pregabalin, opioids), or iron supplementation if ferritin is low.
Who should not take ropinirole 5mg IR?
Same contraindications as other ropinirole formulations: hypersensitivity, severe psychiatric disorders, severe CKD without dose adjustment. The IR 5mg dose carries a higher peak-concentration side effect burden (nausea, orthostatic hypotension) than XL. Patients with cardiovascular instability, significant valvular heart disease (historical ergot dopamine agonist association — though ropinirole is non-ergot), or major psychotic disorders should avoid dopamine agonists. Abrupt discontinuation risk: dopamine agonist withdrawal syndrome (anxiety, panic, sweating) requires gradual tapering.
How does Requip 5mg compare to pramipexole 1mg for Parkinson's disease?
Ropinirole and pramipexole are both non-ergot dopamine agonists. Pramipexole has higher D3 receptor affinity; ropinirole is more D2-selective. Clinical efficacy is similar. Pramipexole is renally cleared — dose reduce in CKD (chronic kidney disease); ropinirole is hepatically metabolised. Both cause similar side effects (nausea, somnolence, orthostatic hypotension, hallucinations, impulse control disorders). Individual patients may respond better to one over the other. When switching, dose conversion tables are used — approximately 1mg pramipexole ≈ 5mg ropinirole in terms of dopaminergic effect.
Is Requip 5mg the same as branded Requip 5mg?
Requip 5mg tablets containing ropinirole 5mg (immediate-release) are the same formulation as branded Requip 5mg. Generic ropinirole IR 5mg provides bioequivalent dopamine receptor stimulation at significantly lower cost than the original branded product — making long-term Parkinson's disease management more affordable without any reduction in therapeutic quality.
Where can I buy Requip 5mg online?
Requip 5mg is available at PremiumRxDrugs.com, which ships to the USA, UK, Australia, and worldwide. Our licensed pharmacy provides authentic manufacturer-sourced ropinirole at competitive prices. Free shipping on qualifying orders, discreet delivery, and easy prescription management make managing Parkinson's disease with dopamine agonist therapy accessible and affordable.
Can I order Requip 5mg from PremiumRxDrugs for delivery to Australia?
Yes. PremiumRxDrugs.com ships Requip 5mg to Australia, the USA, UK, and many other countries. Our genuine manufacturer-verified Parkinson's medications, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international source for patients on ropinirole therapy.
What side effects does Requip 5mg IR cause?
Nausea is very common at higher doses — especially when dose is increased. Somnolence (excessive daytime sleepiness) and sudden sleep attacks require driving caution. Orthostatic hypotension — dizziness on standing — is common and a fall risk. Hallucinations and confusion occur in elderly patients. Impulse control disorders (gambling, hypersexuality, compulsive eating) affect a significant proportion of dopamine agonist users — ask directly at every review. Peripheral oedema. Dopamine agonist withdrawal syndrome on dose reduction.
What precautions apply to Requip 5mg IR?
Never stop abruptly — always taper. Screen for impulse control disorders at each review — patients rarely self-report. Warn about sleep attacks and driving restriction until tolerability is established. Monitor orthostatic blood pressure. Take with food to reduce nausea — domperidone pre-treatment during titration helps. Avoid fluvoxamine. Review dose if patient stops smoking. Alert all prescribers and surgeons to ropinirole use — particularly before general anaesthesia, as dopaminergic drugs may interact with anaesthetic agents.
Login
Sign Up
Login
Sign Up